This documented capability of ZAP to restrict SARS-CoV-2 pandemic viral pathogen might encourage the development of therapies against COVID-19 and IFN-γ is currently considered for treatment of COVID-19 patients [88,89]. Here, IFNG is linked to COVID-19.